Huntington's disease is progressive and affects movement, cognition and mental health. Most people will qualify for PIP, often at enhanced rate. Claim as early as possible – the condition only gets worse.
Struggling to put your difficulties into words?
PIPexpert turns how your condition affects you into the detailed answers the PIP2 form actually asks for. See it work on one activity, completely free.
Try one activity free →Which Activities Does Huntington's Affect?
Preparing Food (Activity 1) – Chorea (involuntary movements) makes handling knives and hot liquids dangerous. Cognitive decline affects recipe following and meal planning. Swallowing difficulties in later stages create choking risk.
Taking Nutrition (Activity 2) – Swallowing difficulties are a major concern. Chorea makes holding cutlery difficult. Increased calorie needs from involuntary movements but difficulty eating enough.
Managing Therapy (Activity 3) – Complex medication for movement, mood and cognition. Cognitive decline making independent medication management impossible.
Communicating Verbally (Activity 7) – Progressive speech deterioration, slurred and eventually unintelligible. Cognitive decline affecting sentence formation.
Engaging with People (Activity 9) – Personality changes, irritability, apathy, social withdrawal. Depression and anxiety extremely common.
Making Budgeting Decisions (Activity 10) – Cognitive decline and impulsivity affecting financial decisions. Most people need someone else to manage finances.
Moving Around (Activity 12) – Balance problems, falls risk, chorea affecting gait, progressive physical decline.
Huntington's is Progressive
Your award should reflect this. At review, scores should increase not decrease. Any reduction is medically indefensible. Ask your neurologist to state: "This is a progressive neurodegenerative condition that will continue to decline."
What Evidence Helps?
- Neurologist letters
- Huntington's Disease Association adviser reports
- OT and speech therapist reports
- Carer statement
Award Length and Reviews
Huntington's is a progressive condition with no cure. Your PIP award should reflect this. DWP assessment guidance says an ongoing award is appropriate for a progressive condition where needs are only likely to increase, with just a light-touch review at the 10-year point. Ask your neurologist to write: "This patient has Huntington's disease, which is a progressive, inherited neurodegenerative condition. There is no treatment that can slow or stop progression. The patient's functional abilities will continue to deteriorate over time."
If the DWP gives you a short award (1-2 years), challenge this at Mandatory Reconsideration. A progressive, incurable condition should receive a long-term or ongoing award.
Genetic Testing and Family Members
If you've tested positive for the Huntington's gene but are not yet showing significant symptoms (pre-symptomatic), you may not currently qualify for PIP. However, early symptoms - subtle cognitive changes, mild chorea, mood disturbances - may already be affecting your daily life more than you realise. If you're noticing difficulties at work, in relationships or with daily tasks, consider claiming now.
Family members who are caring for someone with Huntington's may develop their own health conditions from the stress and physical demands. They can claim PIP for their own conditions and Carer's Allowance for the care they provide.
Swallowing Difficulties and PIP
As Huntington's progresses, swallowing difficulties (dysphagia) become a major concern. This directly affects Activity 2 (Taking Nutrition): choking risk, need for modified texture food, supervision during meals, weight loss from difficulty eating. If speech and language therapy has recommended a modified diet, include their report as evidence.
Huntington's Disease Stages
HD is typically divided into 5 stages:
- Stage 1 (early): Working/independent. Subtle cognitive/motor changes. Often qualifies for standard daily living.
- Stage 2 (mild-moderate): May still work with adjustments. Significant cognitive and motor decline. Often qualifies for enhanced daily living.
- Stage 3 (moderate): Cannot work. Need help with most ADLs. Likely to reach enhanced rates for both components.
- Stage 4 (late): Significant disability. Cannot live independently. Carer support needed.
- Stage 5 (end-stage): Total dependence. Bedbound, mute, often PEG fed. Usually SR1 eligible.
The Triad of Symptoms
HD affects three domains:
- Motor: Chorea (involuntary writhing), dystonia, bradykinesia, dysarthria, dysphagia, gait disturbance, falls
- Cognitive: Executive dysfunction, processing slowing, memory issues, impaired judgment, eventually dementia
- Psychiatric: Depression (very common), anxiety, irritability, apathy, OCD-like behaviours, sometimes psychosis
All three contribute to functional impact. Document each domain separately.
Tetrabenazine and Other Treatments
Treatment is symptomatic only - no disease-modifying therapy yet:
- Tetrabenazine, deutetrabenazine: For chorea. Side effects (depression, sedation) significant.
- Antipsychotics: Quetiapine, olanzapine - for chorea and behaviour
- Antidepressants: SSRIs commonly used
- Mood stabilisers: Sodium valproate, carbamazepine
- Speech therapy: For dysarthria, dysphagia management
- OT input: For ADL adaptations
- PT input: For falls prevention, mobility
Be careful with Activity 3. Needing prompting or help with the medication itself scores 1 point (descriptor 3b) however complex the regime, and appointments add nothing; only prescribed therapy done at home with another person's help, such as swallowing or physiotherapy exercises, is scored by the hours it takes each week (descriptors 3c to 3f, 2 to 8 points). Still list all medications, appointments and therapy, because they are evidence of severity across the other activities.
Juvenile Huntington's Disease (JHD)
Rare form starting before age 21. Different presentation - more rigidity, less chorea. Often more rapid progression. PIP claims for JHD typically qualify quickly for enhanced rates.
The Genetic Aspect
HD is autosomal dominant - 50% inheritance risk. Testing implications:
- Pre-symptomatic positive test: No PIP (no symptoms yet). Mental health support important.
- Early symptomatic: Often qualifies. Document early changes.
- Family members: May qualify for their own conditions (anxiety about future, caregiver burden).
Care Package Considerations
HD typically requires increasing care over years:
- Early stages: family/spouse care
- Middle stages: package of care (direct payments, paid carers)
- Late stages: residential care or NHS Continuing Healthcare
NHS CHC may apply for advanced HD. Care package documentation is excellent PIP evidence.
Frequently Asked Questions
Should I claim PIP early or wait until symptoms worsen?
Claim as early as symptoms affect your daily life. PIP back payments only go back to your claim date, so every week you delay is a week of lost payments. Early symptoms - cognitive slowing, mild chorea, mood changes, balance problems - may already qualify you for standard rate.
My PIP was reduced at review. How is that possible with a progressive condition?
It shouldn't happen, and it's strong grounds for appeal. Request the assessment report and check for errors. Get your neurologist to confirm the condition has NOT improved and cannot improve. Take this to tribunal - panels take a dim view of reduced awards for progressive conditions.
I am gene positive but pre-symptomatic - can I claim?
Generally no, unless you have early symptoms affecting daily life. Many people minimise subtle changes - if you notice cognitive, motor or mood changes, get neurology assessment. Often early changes are PIP-qualifying.
How does HD relate to other conditions like ALS or Parkinson's?
HD is distinct but shares features. Treatment approach overlaps. PIP applies the same functional test - what you can/cannot do reliably.
Will my children automatically have HD?
50% inheritance per child. Genetic counselling helps. DLA (under 16) or PIP (16 or over) may apply if they show juvenile onset features.
What about new treatments like Tominersen?
Several gene-targeting therapies are in clinical trials. None approved for general use yet. Trial participation itself does not score under Activity 3 (hospital visits, lumbar punctures for intrathecal delivery and clinic monitoring are not therapy done at home), but trial records are useful evidence of severity.
How can the Huntington's Disease Association help?
HDA (0151 331 5444) has specialist advisers in each region. They help with PIP, NHS Continuing Healthcare, social services, genetic testing decisions. Free service.
Need help with your PIP form?
PIPexpert generates personalised PIP2 answers for all 12 activities based on your specific conditions. You can try one activity completely free to see what it produces.